Body dysmorphic disorder;Trastorno dismórfico corporal

Dialogues in Clinical Neuroscience

Volumn 12, Issue 2, 2010, Pages 221-232

  Bjornsson, Andri S ^a   Didie, Elizabeth R ^a   Phillips, Katharine A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Body dysmorphic disorder; Clinical feature; Delusional disorder; Dysmorphophobia; Epidemiology; Obsessive compulsive spectrum; Somatoform disorder; Treatment

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; ESCITALOPRAM; ETIRACETAM; FLUOXETINE; FLUVOXAMINE; OLANZAPINE; PIMOZIDE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ARTICLE; AVOIDANCE BEHAVIOR; BODY DYSMORPHIC DISORDER; CLINICAL FEATURE; COGNITION; COGNITIVE THERAPY; COMORBIDITY; COMPULSION; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG EFFICACY; ESTHETIC SURGERY; HIGH RISK BEHAVIOR; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; SAFETY; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; TREATMENT RESPONSE; VIOLENCE; CASE REPORT; FEMALE; MALE; METHODOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; REVIEW; RISK FACTOR; SUICIDE;

BODY DYSMORPHIC DISORDERS; COGNITIVE THERAPY; COMORBIDITY; FEMALE; HUMANS; MALE; PSYCHOLOGY; QUALITY OF LIFE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SUICIDE;

EID: 77955487502     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (138)

1. Phillips KA. Understanding Body Dysmorphic Disorder: an Essential Guide. New York, NY: Oxford University Press; 2009.
2. Phillips KA. Body dysmorphic disorder: the distress of imagined ugliness. Am J Psychiatry. 1991;148:1138-1149.
3. Morselli E. Sulla dismorfofobia e sulla tafefobia. Bolletinno della R Accademia di Genova. 1891;6:110-119.
4. Kraepelin E. Psychiatrie. Oxford, UK: J A Barth; 1896.
5. Janet P. Les Obsessions et la Psychasthenie. Paris, France: Felix Alcan; 1903.
6. Phillips KA. The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder (2nd ed, revised). New York, NY: Oxford University Press; 2005.
7. Phillips KA, McElroy SL, Keck PE, Jr, Pope HG, Jr, Hudson JI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry. 1993;150:302-308.
8. Phillips KA, Nierenberg AA, Brendel G, Fava M. Prevalence and clinical features of body dysmorphic disorder in atypical major depression. J Nerv Ment Dis. 1996;184:125-129.
9. Grant JE, Kim SW, Crow SJ. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry. 2001;62:517-522.
10. Dyl J, Kittler J, Phillips KA, Hunt JI. Body dysmorphic disorder and other clinically significant body image concerns in adolescent psychiatric inpatients: prevalence and clinical characteristics. Child Psychiatry Hum Dev. 2006;36:369-382.
11. Zimmerman M, Mattia JI. Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Compr Psychiatry. 1998;39:265-270.
12. Thompson CM, Durrani AJ. An increasing need for early detection of body dysmorphic disorder by all specialties. J R Soc Med. 2007;100:61-62.
13. Phillips KA, Kaye WH. The relationship of body dysmorphic disorder and eating disorders to obsessive-compulsive disorder. CNS Spectr. 2007;12:347-358.
14. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/PSY SCREEN). New York, NY: Biometrics Research NYSPI; 2002.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, Text Revision. Washington, DC: American Psychiatric Association; 2000.
16. Ruffulo JS, Phillips KA, Menard W, Fay C, Weisberg R. Comorbidity of body dysmorphic disorder and eating disorders: severity of psychopathology and body image disturbance. Int J Eat Disord. 2006;39:11-19.
17. Phillips KA, Wilhelm S, Koran LM, et al. Body dysmorphic disorder: Some key issues for DSM-V. Depress Anxiety. In press.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987.
20. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders. Clinical descriptions and diagnostic guidelines. Geneva, Switzerland: World Health Organization; 1992.
21. Phillips KA, Hollander E. Body dysmorphic disorder. In: Widiger TA, Frances AJ, Pincus HA, Ross R, First MB, Davis WW, eds. DSM-IV Sourcebook. Washington, DC: American Psychiatric Association; 1996.
22. Phillips KA, Stein DJ, Rauch SL, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety. In press.
23. Phillips KA, McElroy SL, Keck PE, Pope HG, Hudson JI. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull. 1994;30:179-186.
24. McElroy SL, Phillips KA, Keck PE, Hudson JI. Body dysmorphic disorder: does it have a psychotic subtype? J Clin Psychiatry. 1993;54:389-395.
25. Mancuso S, Knoesen N, Castle DJ. Delusional vs nondelusional body dysmorphic disorder. Compr Psychiatry. 2010;51:177-182.
26. Phillips KA, Hollander E. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image. 2008;5:13-27.
27. Faravelli C, Salvatori S, Galassi F, Aiazzi L, Drei C, Cabras P. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol. 1997;32:24-29.
28. Koran LM, Abujaoude E, Large MD, Serpe RT. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectr. 2008;13:316-322.
29. Otto MW, Wilhelm S, Cohen LS, Harlow BL. Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry. 2001;158:2061-2063.
30. Rief W, Buhlmann U, Wilhelm S, Borkenhagen A, Brahler E. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med. 2006;36:877-885.
31. Biby EL. The relationship between body dysmorphic disorder and depression, self-esteem, somatization, and obsessive-compulsive disorder. J Clin Psychol. 1998;54:489-499.
32. Bohne A, Wilhelm S, Keuthen NJ, Florin I, Baer L, Jenike MA. Prevalence of body dysmorphic disorder in a German college student sample. Psychiatry Res. 2002;109:101-104.
33. Cansever A, Uzun O, Donmez E, Ozsahin A. The prevalence and clinical features of body dysmorphic disorder in college students: a study in a Turkish sample. Compr Psychiatry. 2003;44:60-64.
34. Mayville S, Katz RC, Gipson MT, Cabral K. Assessing the prevalence of body dysmorphic disorder in an ethnically diverse group of adolescents. J Child Fam Stud. 1999;8:357-362.
35. Taqui AM, Shaikh M, Gowani SA, et al. Body dysmorphic disorder: Gender differences and prevalence in a Pakistani medical student population. BCM Psychiatry. 2008;8:20.
36. Hollander E, Cohen LJ, Simeon D. Body dysmorphic disorder. Psychiatr Ann. 1993;23:359-364.
37. Aouizerate B, Pujol H, Grabot D, et al. Body dysmorphic disorder in a sample of cosmetic surgery applicants. Eur Psychiatry. 2003;18:365-368.
38. Brawman-Mintzer O, Lydiard RB, Phillips KA, et al. Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry. 1995;152:1665-1667.
39. Castle DJ, Molton M, Hoffman K, Preston NJ, Phillips KA. Correlates of dysmorphic concern in people seeking cosmetic enhancement. Aust NZ J Psychiatry. 2004;38:439-444.
40. Ishigooka J, Iwao M, Suzuki M, Fukuyama Y, Murasaki M, Miura S. Demographic features of patients seeking cosmetic surgery. Psychiatry Clin Neurosci. 1998;52:283-287.
41. Kelly KE, Alpert JE, Worthington JJ, et al. Body dysmorphic disorder in outpatients with major depression. J Affect Disord. 2002;69:141-148.
42. Perugi G, Giannotti D, Frare F, et al. Prevalence, phenomenology and comorbidity of body dysmorphic disorder (dysmorphophobia) in a clinical population. Int J Psych Clin Pract. 1997;1:77-82.
43. Phillips KA, Dufresne RG, Jr, Wilkel CS, Vittorio CC. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol. 2000;42:436-441.
44. Sarwer DB, Wadden TA, Pertschuk MJ, Whitaker LA. Body image dissatisfaction and body dysmorphic disorder in 100 cosmetic surgery patients. Plast Reconstr Surg. 1998;101:1644-1649.
45. Soriano JL, O'Sullivan RL, Baer L, Phillips KA, McNally RJ, Jenike MA. Trichotillomania and self-esteem: a survey of 62 female hair pullers. J Clin Psychiatry. 1996;57:77-82.
46. Uzun O, Basoglu C, Akar A, et al. Body dysmorphic disorder in patients with acne. Compr Psychiatry. 2003;44:415-419.
47. Vargel S, Ulusahin A. Psychopathology and body image in cosmetic surgery patients. Aesthetic Plast Surg. 2001;25:474-478.
48. Vindigni V, Pavan C, Semenzin M, et al. The importance of recognizing body dysmorphic disorder in cosmetic surgery patients: do our patients need a preoperative psychiatric evaluation? Eur J Plast Surg. 2002;25:305-308.
49. Wilhelm S, Otto MW, Zucker BG, Pollack MH. Prevalence of body dysmorphic disorder in patients with anxiety disorders. J Anxiety Disord. 1997;11:499-502.
50. Conroy M, Menard W, Fleming-Ives K, Modha P, Cerullo H, Phillips KA. Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting. Gen Hosp Psychiatry. 2008;30:67-72.
51. Albertini RS, Phillips KA, Guevremont D. Body dysmorphic disorder in a young child (letter). J Am Acad Child Adolesc Psychiatry. 1996;35:1425-1426.
52. Phillips KA, Diaz SF. Gender differences in body dysmorphic disorder. J Nerv Ment Dis. 1997;185:570-577.
53. Phillips KA, Menard W, Fay C. Gender similarities and differences in 200 individuals with body dysmorphic disorder. Compr Psychiatry. 2006;47:77-87.
54. Didie ER, Menard W, Stern AP, Phillips KA. Occupational functioning and impairment in adults with body dysmorphic disorder. Compr Psychiatry. 2008;24:26-28.
55. Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics. 2005;46:317-325.
56. Pope HG, Jr., Gruber AJ, Choi P, Olivardia R, Phillips KA. Muscle dysmorphia: an underrecognized form of body dysmorphic disorder. Psychosomatics. 1997;38:548-557.
57. Olivardia R, Pope HG, Jr., Hudson JI. Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry. 2000;157:1291-1296.
58. Pope CG, Pope HG, Menard W, Fay C, Olivardia R, Phillips KA. Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image. 2005;2:395-400.
59. Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry. 1998;155:102-108.
60. Phillips KA, Menard W, Pagano ME, Fay C, Stout RL. Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. J Psychiatr Res. 2006;40:95-104.
61. Eisen JL, Phillips KA, Coles ME, Rasmussen SA. Insight in obsessive compulsive disorder and body dysmorphic disorder. Compr Psychiatry. 2004;45:10-15.
62. Phillips KA. Psychosis in body dysmorphic disorder. J Psychiatr Res. 2004;38:63-72.
63. Phillips KA, Gunderson CG, Mallya G, McElroy SL, Carter W. A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J Clin Psychiatry. 1998;59:568-575.
64. Veale D, Riley S. Mirror, mirror on the wall, who is the ugliest of them all? The psychopathology of mirror gazing in body dysmorphic disorder. Behav Res Ther. 2001;39:1381-1393.
65. Feusner JD, Hembacher E, Phillips KA. The mouse who couldn't stop washing: pathologic grooming in animals and humans. CNS Spectr. 2009;14:503-513.
66. Phillips KA, Conroy M, Dufresne RG, et al. Tanning in body dysmorphic disorder. Psychiatr Q. 2006;77:129-138.
67. Grant JE, Menard W, Phillips KA. Pathological skin picking in individuals with body dysmorphic disorder. Gen Hosp Psychiatry. 2006;28:487-493.
68. O'Sullivan RL, Phillips KA, Keuthen NJ, Wilhelm S. Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine. Psychosomatics. 1999;40:79-81.
69. Phillips KA, Taub SL. Skin picking as a symptom of body dysmorphic disorder. Psychopharmacol Bull. 1995;31:279-288.
70. Kelly M, Walters C, Phillips K. Social anxiety and its relationship to functional impairment in body dysmorphic disorder. Behav Ther. 2010;41:143-153.
71. Pinto A, Phillips KA. Social anxiety in body dysmorphic disorder. Body Image. 2005;2:401-405.
72. Veale D. Advances in a cognitive behavioural model of body dysmorphic disorder. Body Image. 2004;1:113-125.
73. Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry. 2003;44:270-276.
74. Phillips KA, Pagano ME, Menard W, Stout RL. A 12-month follow-up study of the course of body dysmorphic disorder. Am J Psychiatry. 2006;163:907-912.
75. Phillips KA, Pagano ME, Menard W, Fay C, Stout RL. Predictors of remission from body dysmorphic disorder: a prospective study. J Nerv Ment Dis. 2005;193:564-567.
76. Phillips KA. Quality of life for patients with body dysmorphic disorder. J Nerv Ment Dis. 2000;188:170-175.
77. Phillips KA, Menard W, Fay C, Pagano ME. Psychosocial functioning and quality of life in body dysmorphic disorder. Compr Psychiatry. 2005;46:254-260.
78. Phillips KA, Quinn G, Stout RL. Functional impairment in body dysmorphic disorder: a prospective, follow-up study. J Psychiatr Res. 2008;42:701-707.
79. Phillips KA. Suicidality in body dysmorphic disorder. Primary Psychiatry. 2007;14:58-66.
80. Phillips KA, Coles ME, Menard W, Yen S, Fay C, Weisberg RB. Suicidal ideation and suicide attempts in body dysmorphic disorder. J Clin Psychiatry. 2005;66:717-725.
81. Veale D, Boocock A, Gournay K, Dryden W. Body dysmorphic disorder: a survey of fifty cases. Br J Psychiatry. 1996;169:196-201.
82. Phillips KA, Menard W. Suicidality in body dysmorphic disorder: a prospective study. Am J Psychiatry. 2006;163:1280-1282.
83. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: a metaanlysis. Br J Psychiatry. 1997;170:205-228.
84. Perugi G, Akiskal HS, Giannotti D, Frare F, Di Vaio S, Cassano GB. Gender-related differences in body dysmorphic disorder (dysmorphophobia). J Nerv Ment Dis. 1997;185:578-582.
85. Sarwer DB. Awareness and identification of body dysmorphic disorder by aesthetic surgeons: results of a survey of american society for aesthetic plastic surgery members. Aesthet Surg J. 2002;22:531-535.
86. Grant JE, Menard W, Pagano ME, Fay C, Phillips KA. Substance use disorders in individuals with body dysmorphic disorder. J Clin Psychiatry. 2005;66:309-316.
87. Albertini RS, Phillips KA. 33 cases of body dysmorphic disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38:453-459.
88. Phillips KA, Didie ER, Menard W, Pagano ME, Fay C, Weisberg RB. Clinical features of body dysmorphic disorder in adolescents and adults. Psychiatry Res. 2006;141:305-314.
89. Phillips KA, Atala KD, Albertini RS. Case study body dysmorphic disorder in adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34:1216-1220.
90. Cull J, Gill W. Suicide Probability Scale. Los Angeles, CA: WPS; 1982.
91. Deckersbach T, Savage CR, Phillips KA, et al. Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc. 2000;6:673-681.
92. Feusner JD, Townsend J, Bystritsky A, Bookheimer S. Visual information processing of faces in body dysmorphic disorder. Arch Gen Psychiatry. 2007;64:1417-1425.
93. Buhlmann U, Reese HE, Renaud S, Wilhelm S. Clinical considerations for the treatment of body dysmorphic disorder with cognitive-behavioral therapy. Body Image. 2008;5:39-49.
94. Buhlmann U, Etcoff NL, Wilhelm S. Emotion recognition bias for contempt and anger in body dysmorphic disorder. J Psychiatr Res. 2006;40:105-111.
95. Buhlmann U, McNally RJ, Etcoff NL, Tuschen-Caffier B, Wilhelm S. Emotion recognition deficits in body dysmorphic disorder. J Psychiatr Res. 2004;38:201-206.
96. Rauch SL, Phillips KA, Segal E, et al. A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res. 2003;122:13-19.
97. Atmaca M, Bingol I, Aydin A, et al. Brain morphology of patients with body dysmorphic disorder. J Affect Disord. 2009;123:701-707.
98. Feusner JD, Townsend J, Bystritsky A, McKinley M, Moller H, Bookheimer S. Regional brain volumes and symptom severity in body dysmorphic disorder. Psychiatry Res. 2009;172:161-167.
99. Carey P, Seedat S, Warwick J, van Heerden B, Stein DJ. SPECT imaging of body dysmorphic disorder. J Neuropsychiatry Clin Neurosci. 2004;16:357-359.
100. Feusner JD, Moody T, Hembacher E. Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. Arch Gen Psychiatry. In press.
101. Rotge JY, Guehl D, Dilharreguy B, et al. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry. 2009;65:75-83.
102. Crerand CE, Phillips KA, Menard W, Fay C. Nonpsychiatric medical treatment of body dysmorphic disorder. Psychosomatics. 2005;46:549-555.
103. Phillips KA, Grant J, Siniscalchi J, Albertini RS. Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics. 2001;42:504-510.
104. Ipser J, Sander C, Stein D. Pharmacotherapy and psychotherapy for body dysmorphic disorder. Available at: http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005332/ab stract.html. Cochrane Database Syst Rev. Accessed May 24, 2010.
105. Obsessive compulsive disorder: core interventions in the treatment of obsessive compulsive disorder and body dysmorphic disorder. Available at: http://www.nice.org.uk/nicemedia/pdf/cg031niceguideline.pdf. National Institute for Health and Clinical Excellence. Accessed May 24, 2010.
106. Hollander E, Allen A, Kwon J, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry. 1999;56:1033-1039.
107. Perugi G, Giannotti D, Di Vaio S, Frare F, Saettoni M, Cassano GB. Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol. 1996;11:247-254.
108. Phillips KA. An open-label study of escitalopram in body dysmorphic disorder. Int Clin Psychopharmacol. 2006;21:177-179.
109. Phillips KA, Dwight MM, McElroy SL. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 1998;59:165-171.
110. Phillips KA, Najar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry. 2003;64:715-720.
111. Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002;59:381-388.
112. Hollander E, Cohen LJ, Simeon D, Rosen J, deCaria CM, Stein D. Fluvoxamine treatment of body dysmorphic disorder. J Clin Psychopharmacol. 1994;14:75-77.
113. Hollander E, Liebowitz MR, Winchel R, Klumker A, Klein DF. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry. 1989;146:768-770.
114. Phillips KA. An open study of buspirone augmentation of serotoninreuptake inhibitors in body dysmorphic disorder. Psychopharmacol Bull. 1996;32:175-180.
115. Phillips KA, Albertini RS, Siniscalchi JM, Khan A, Robinson M. Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. J Clin Psychiatry. 2001;62:721-727.
116. Phillips KA, Rasmussen SA. Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study. Psychosomatics. 2004;45:438-444.
117. Grant JE. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: A case report. J Clin Psychiatry. 2001;62:297-298.
118. Nakaaki S, Murata Y, Furukawa TA. Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder. Psychiatry Clin Neurosci. 2008;62:370.
119. Phillips KA. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry. 2005;162:377-379.
120. Phillips KA. Olanzapine augmentation of fluoxetine in body dysmorphic disorder (letter). Am J Psychiatry. 2005;162:1022-1023.
121. Allen A, Hadley SJ, Kaplan A, et al. An open-label trial of venlafaxine in body dysmorphic disorder. CNS Spectr. 2008;13:138-144.
122. Phillips KA, Menard W. A prospective pilot study of levetiracetam for body dysmorphic disorder. CNS Spectr. 2009;14:252-260.
123. Veale D, Gournay K, Dryden W, et al. Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav Res Ther. 1996;34:717-729.
124. Wilhelm S, Otto MW, Lohr B, Deckersbach T. Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behav Res Ther. 1999;37:71-75.
125. Phillips KA, Didie ER, Feusner J, Wilhelm S. Body dysmorphic disorder: treating an underrecognized disorder. Am J Psychiatry. 2008;165:1111-1118.
126. Wilhelm S, Phillips KA, Steketee G. A Cognitive Behavioral Treatment Manual for Body Dysmorphic Disorder. New York, NY: Guilford Press. In press.
127. Marks IM, Mishan J. Dysmorphophobic avoidance with disturbed bodily perception: A pilot study of exposure therapy. Br J Psychiatry. 1988;152:674-678.
128. Neziroglu F, Khemlani-Patel S. A review of cognitive and behavioral treatment for body dysmorphic disorder. CNS Spectr. 2002;7:464-471.
129. Neziroglu F, McKay D, Todaro J, Yaryura-Tobias JA. Effect of cognitive behavior therapy on persons with body dysmorphic disorder and comorbid Axis II diagnosis. Behav Ther. 1996;27:67-77.
130. McKay D. Two-year follow-up of behavioral treatment and maintenance for body dysmorphic disorder. Behav Modif. 1999;23:620-629.
131. Rosen JC, Reiter J, Orosan P. Cognitive-behavioral body image therapy for body dysmorphic disorder. J Consult Clin Psychol. 1995;63:263-269.
132. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, NY: Guilford Press; 1991.
133. Didie ER, Kurahara L, Menard W, Phillips KA. Adherence to cognitive behavioral therapy and pharmacotherapy recommendations among patients with body dysmorphic disorder. Poster presented at: the annual meeting of the Association for Behavioral and Cognitive Therapies; November; 2008; Orlando, FL.
134. Didie ER, Tortolani CC, Pope CG, Menard W, Fay C, Phillips KA. Childhood abuse and neglect in body dysmorphic disorder. Child Abuse Negl. 2006;30:1105-1115.
135. Didie ER, Loerke E, Menard W, Phillips KA. Severity of interpersonal problems in individuals with body dysmorphic disorder. Poster presented at: the annual meeting of the NIMH New Clinical Drug Evaluation Unit; 2008; Phoenix, AZ.
136. Kerman GL, Weismann MM, Rousanville BA, Chevron ES. Interpersonal Psychotherapy of Depression. New York, NY: Basic Books; 1984.
137. Fairburn CG. Interpersonal therapy for bulimia nervosa. In: Garner DM, Garfinkel PE, eds. Handbook of Treatment for Eating Disorders. New York, NY: Guilford Press; 1997:67-93.
138. Didie ER, Phillips KA. Interpersonal psychotherapy for body dysmorphic disorder: a pilot study. Poster presented at: the annual meeting of the International Society for Interpersonal Psychotherapy; March, 2009; New York, NY.